Xeris Biopharma Holdings Inc. buy Piper Sandler
Start price
10.05.24
/
50%
€1.64
Target price
10.05.25
€2.78
Performance (%)
19.28%
Price
15:49
€1.96
Summary
This prediction is currently active. The prediction currently has a performance of 19.28%. This prediction currently runs until 10.05.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Xeris Biopharma Holdings Inc. | -5.092% | -5.092% |
iShares Core DAX® | -0.315% | -2.776% |
iShares Nasdaq 100 | 1.250% | 7.480% |
iShares Nikkei 225® | -1.284% | -2.199% |
iShares S&P 500 | 1.141% | 4.717% |
Comments by Piper_Sandler for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $3.00 price target on the stock, down previously from $4.00.
Ratings data for XERS provided by MarketBeat
Stopped prediction by Piper_Sandler for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.60
10.11.23
10.11.23
€3.74
10.11.24
10.11.24
22.19%
15:49
15:49